Hero N° 05 sits inside the beauty category — one of sixteen launches in a portfolio built around modern science layered onto inherited ritual.
Each hero in the portfolio is a deliberate bet on a specific consumer shift: away from default Western formats, toward functional, ingredient-honest products with provable mechanisms. This page is the public-facing brief. The full thesis — formulation, unit economics, supply chain, founder background — lives behind the deal-room door.
The category default was built for a consumer that no longer exists. The new buyer reads labels, demands mechanism, and pays a premium for honesty.
A repeatable daily ritual the incumbent brand has owned for thirty years — and is about to lose.
Functional, ingredient-honest CPG is the only growth pocket left in a flat category. The incumbents cannot reformulate without cannibalising their core.
The literate, premium consumer who has already left the legacy brand and is looking for what comes next.
We do not invent rituals. We replace the product inside one. Each hero in the portfolio sits on a specific, repeatable moment in the consumer's day — one the incumbent has owned for a generation and is now losing.
01
Daily
The defensible ritual
Each SKU sits inside a daily or weekly habit the consumer already performs. We do not create the ritual — we replace the product inside it.
02
Weekly
The repeat
Repeat-purchase frequency is the most underrated moat in CPG. The portfolio is built around it.
03
Yearly
The compounding
Sixteen rituals, sixteen baskets, one operating system. The portfolio is the moat.
The incumbent shelf
- —Legacy CPG
- —Mass-market wellness
- —Drugstore brands
- —DTC novelty
The new wave
- +Mechanism-led functional
- +Heritage-ritual modernised
- +Clinical-dose single-ingredient
- +Premium provenance pantry
"The next generation of consumer brands will be built by founders who can hold both the science and the story in one hand."
$8.4B global ingestible beauty market, 14.2% CAGR.
Moon Juice, The Nue Co., and Lemme have proven the willingness to pay $40–80/month for ingestible beauty. None have an Ayurvedic axis or measured outcomes. That is a defensible position.
The product specifics — the proprietary formulation, the brand architecture, the channel strategy, the unit economics — are deliberately not on this page. We don't publish the recipe to the open internet.
- Full formulation & ingredient stack
- Clinical and mechanism-of-action references
- Founder thesis and category positioning
- Unit economics and pricing model
- Supply chain and manufacturing partner
- Go-to-market plan and channel mix
- Why a portfolio, not one brand?
- Distribution and operations compound across SKUs. One investor letter, sixteen entry points. The portfolio model is the unfair advantage.
- What's the IP protection?
- Formulation, brand architecture, and channel strategy live in the gated deal-room. We do not publish the recipe.
- How do I get access?
- Request the deal-room. Approvals are by hand, usually within 48 hours.
The next move.
The investor deck, unit economics, and a direct line to the founder live behind the deal-room door. Or stay close to the portfolio with a monthly subscriber drop — first look on every new SKU.
